RS
KRYS icon

Rakuten Securities’s Krystal Biotech KRYS Stock Holding History

Rakuten Securities’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.8K Buy
+21
New +$6.27K ﹤0.01% 496
2026
Q1 		– Sell
-1
Closed -$247 – 927
2025
Q4 		$247 Sell
1
-4
-80% -$842 ﹤0.01% 802
2025
Q3 		$883 Hold
5
– – ﹤0.01% 724
2025
Q2 		$687 Hold
5
– – ﹤0.01% 697
2025
Q1 		$902 Sell
5
-15
-75% -$2.52K ﹤0.01% 677
2024
Q4 		$3.13K Buy
20
+4
+25% +$710 ﹤0.01% 522
2024
Q3 		$2.91K Buy
+16
New +$3.08K ﹤0.01% 478

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Rakuten Securities's KRYS Position: Q2 2026 in Review

Rakuten Securities opened a new position in Krystal Biotech (KRYS) in Q2 2026: 21 shares worth $7.8K. The stake represents ﹤0.01% of the portfolio and ranks #496 among its holdings. This is a return to the name: Rakuten Securities previously reported a position in KRYS as recently as Q4 2025.

Rakuten Securities first reported a position in KRYS in Q3 2024 and has held it in 7 quarters since. 424 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Rakuten Securities held 21 shares of Krystal Biotech worth $7.8K as of Q2 2026.
  • Krystal Biotech was a new Rakuten Securities position in Q2 2026.
  • Krystal Biotech made up ﹤0.01% of Rakuten Securities's portfolio in Q2 2026, its #496 holding.
  • Rakuten Securities first reported a position in Krystal Biotech in Q3 2024 and has held it in 7 quarters since.
  • 424 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Rakuten Securities's 13F filing for Q2 2026, filed 12 Aug 2026.